Related Experiment Video
Updated: Jan 13, 2026
08:54
Immunostaining of Biocytin-filled and Processed Sections for Neurochemical Markers
Published on: December 31, 2016
23.8K
Interneurons. Fast-spiking, parvalbumin⁺ GABAergic interneurons: from cellular design to microcircuit function
Hua Hu1, Jian Gan1, Peter Jonas2
1IST Austria (Institute of Science and Technology Austria), Am Campus 1, A-3400 Klosterneuburg, Austria.
Science (New York, N.Y.)
|August 2, 2014
Summary
Fast-spiking, parvalbumin-positive (PV(+)) GABAergic interneurons are crucial for understanding the brain. Advanced techniques have significantly expanded knowledge of these cells, paving the way for potential therapeutic applications in neurological disorders.
Area of Science:
- Neuroscience
- Cellular Biology
- Computational Neuroscience
Background:
- Parvalbumin-positive (PV(+)) GABAergic interneurons were poorly understood in 1995.
- Recent advancements have dramatically increased knowledge of these critical brain cells.
Purpose of the Study:
- To highlight the significant progress in understanding PV(+) interneurons.
- To underscore the potential of PV(+) interneurons as therapeutic targets for brain diseases.
- To identify future research directions for bridging molecular, cellular, network, and behavioral levels.
Main Methods:
- Subcellular patch-clamp techniques
- Simultaneous multiple-cell recordings
- Optogenetics
- In vivo measurements
- Computational approaches
Main Results:
- Extensive knowledge gained on PV(+) interneurons, surpassing that of some pyramidal neurons.
- Demonstrated feasibility of integrating molecular, cellular, network, and behavioral data.
- Established a foundation for exploring PV(+) interneurons in brain disease therapeutics.
Conclusions:
- The study of PV(+) interneurons has seen remarkable progress, driven by technological innovation.
- PV(+) interneurons represent a promising avenue for future therapeutic interventions in neurological conditions.
- Further research is essential to fully elucidate their basic functions for clinical applications.
